Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Moderna Capitalizes On COVID-19 Vaccine Data Value Boost

May 20 2020

• By Mandy Jackson

Finance Watch

Related Content

Keeping Track: Submissions From Alkermes, Samsung Bioepis; BTDs for Orphazyme and Kiniksa

Nov 24 2019

Deal Watch: Gilead Moves Into Kidney Disease Via Goldfinch Collaboration

May 09 2019

Finance Watch: Gossamer Works Around The Shutdown To Price Its $230m IPO

Jan 26 2019

Clear Path For AstraZeneca’s Roxadustat After Reassuring Safety Data

Nov 11 2019

IPO Update: New Offerings Outperform As September Ends With Biopharma Trifecta

Sep 29 2017

Finance Watch: Turning Point Launches IPO, Stock Rises 60% On First Day

Apr 17 2019

Syndax Sees Subgroup Efficacy For Entinostat Plus Keytruda In NSCLC

May 18 2018

Finance Watch: Six More IPO Filings As Three More Biopharmas Go Public In The US

May 27 2018

Finance Watch: Moderna Launches Biggest Biopharma IPO Ever As US Market Resets Expectations

Dec 11 2018

Finance Watch: A Plethora Of Big Rounds, Led By Gossamer's $230m Series B

Jul 31 2018

TG Therapeutics Raises $60m Following Combo Therapy Success In CLL

May 06 2020

A BCMA Setback For Bristol And Bluebird With FDA Refuse-To-File Letter

May 14 2020

Pipeline Watch: Phase III Readouts For Lupin, Akebia And TG Therapeutics

May 12 2020

Gamida Cell’s Bone Marrow Transplant Alternative Succeeds In Phase III

May 13 2020

Bluebird Revises Business Priorities And Secures Upfront Cash From Bristol

May 11 2020

Axcella Addresses Metabolic Disease Quickly With GRAS Candidates

Feb 19 2020

Coronavirus Update: Moderna Lifted By BARDA funding, Europe Looks For Exit Strategy, Vaccine Funds

Apr 17 2020

Immunomedics' Trodelvy Will Be First ADC For Triple-Negative Breast Cancer

Apr 23 2020

BioMarin Prepares To Launch Roctavian For Hemophilia In An Uncertain Environment

Apr 30 2020

Related Companies

Moderna, Inc.

Genetix Biotherapeutics

Bristol Myers Squibb Company

Pfizer Inc.

Bausch Health Companies Inc.

MyoKardia, Inc.

BioMarin Pharmaceutical Inc.

Immunomedics, Inc.

Turning Point Therapeutics Inc.

Gossamer Bio, Inc.

TG Therapeutics, Inc.

Akebia Therapeutics, Inc.

AstraZeneca PLC

FibroGen, Inc.

Krystal Biotech, Inc.

Syndax Pharmaceuticals, Inc.

Protagonist Therapeutics, Inc.

Johnson & Johnson

Clovis Oncology, Inc.

Kiniksa Pharmaceuticals Corporation

Axcella Therapeutics, Inc.

Gamida Cell Ltd.

Additional Topics

Financing Business Strategies Coronavirus COVID-19 Innovation Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window